Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma. (Q54077157)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma. |
scientific article |
Statements
Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma. (English)
1 reference
Buzdar AU
1 reference
Ibrahim NK
1 reference
Rahman Z
1 reference
Valero V
1 reference
Willey J
1 reference
Theriault RL
1 reference
Murray JL 3rd
1 reference
Bast R
1 reference
Hortobagyi GN
1 reference
1 October 1999
1 reference
1 reference
86
1 reference
7
1 reference
1251-1257
1 reference
Identifiers
1 reference